Skip to main navigation Skip to search Skip to main content

E2FBP1/DRIL1, an AT-rich interaction domain-family transcription factor, is regulated by p53

  • Kaiwen Ma
  • , Keigo Araki
  • , Solachuddin J.A. Ichwan
  • , Tamaki Suganuma
  • , Mimi Tamamori-Adachi
  • , Masa Aki Ikeda
  • Institute of Science Tokyo

Research output: Contribution to journalArticlepeer-review

31 Scopus citations

Abstract

E2FBP1/DRIL1 is an AT-rich interaction domain DNA-binding protein and is ubiquitously expressed in various tissues. It has been shown that Bright, the mouse orthologue of E2FBP1/DRIL1, exhibits sequence-specific DNA binding and regulates immunoglobulin transcription. Here we show a novel connection between E2FBP1/DRIL1 and the p53 tumor suppressor, a key regulator of growth arrest or apoptosis in response to cellular stress. We found a putative p53-binding site, which specifically responded to p53, in the second intron of the E2FBP1/DRIL1 gene. E2FBP1/DRIL1 was induced by p53 and upregulated following DNA damage caused by UV radiation or doxorubicin treatment in a manner dependent on endogenous p53. The ectopic expression of E2FBP1/DRIL1 induced growth arrest in U2OS cells expressing normal p53, but not Saos-2 cells lacking p53. These results suggest that E2FBP1/DRIL1 may play a role in growth suppression mediated by p53.

Original languageEnglish
Pages (from-to)438-444
Number of pages7
JournalMolecular Cancer Research
Volume1
Issue number6
StatePublished - 1 Apr 2003
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'E2FBP1/DRIL1, an AT-rich interaction domain-family transcription factor, is regulated by p53'. Together they form a unique fingerprint.

Cite this